Vertex has the revenue power to excel during any market environment.

Legend Biotech Corporation (NASDAQ:LEGN) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Legend ...

AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.

Despite the headline jump, local brokers describe a market that still feels slow. As reported by Crain's New York Business, CBRE Vice Chairman William Hartman said demand is "still pretty anemic" even ...